Assessing Whether Community Health Systems, Inc (NYSE: CYH) Is Over- Or Undervalued

Community Health Systems, Inc (CYH) concluded trading on Thursday at a closing price of $2.88, with 10.51 million shares of worth about $30.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.91% during that period and on April 24, 2025 the price saw a gain of about 18.52%. Currently the company’s common shares owned by public are about 140.30M shares, out of which, 121.36M shares are available for trading.

Stock saw a price change of 14.29% in past 5 days and over the past one month there was a price change of 2.49%. Year-to-date (YTD), CYH shares are showing a performance of -3.68% which increased to 1.41% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.24 but also hit the highest price of $6.29 during that period. The average intraday trading volume for Community Health Systems, Inc shares is 2.69 million. The stock is currently trading 13.05% above its 20-day simple moving average (SMA20), while that difference is up 0.82% for SMA50 and it goes to -27.60% lower than SMA200.

Community Health Systems, Inc (NYSE: CYH) currently have 140.30M outstanding shares and institutions hold larger chunk of about 76.74% of that.

The stock has a current market capitalization of $404.08M and its 3Y-monthly beta is at 2.01. It has posted earnings per share of -$3.68 in the same period. It has Quick Ratio of 1.30. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CYH, volatility over the week remained 7.71% while standing at 7.33% over the month.

Stock’s fiscal year EPS is expected to rise by 72.78% while it is estimated to increase by 120.72% in next year.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on November 25, 2024 offering an Underweight rating for the stock and assigned a target price range of between $5 and $2.50 to it. On March 06, 2024, Barclays Initiated their recommendations, while on June 17, 2022, Loop Capital Initiated their ratings for the stock with a price target of $5. Stock get a Neutral rating from BofA Securities on June 15, 2022.

Most Popular

Related Posts